For example, NRF2 activity promoted tumourigenesis in a genetically-engineered mouse model of pancreatic cancer, at least in part by mitigating oncogene-driven ROS formation [12]. This evidence concerns the gene NFE2L2 and familial pancreatic carcinoma.